GAMMA Investing »

Xtl Biopharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Xtl Biopharmaceuticals (XTLB) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Xtl Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xtl Biopharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xtl Biopharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.2k 3.4k 2.41

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Ishares Inc Core Msci Emkt Etf (IEMG)
Tesla Common Stock (TSLA)
Ishares Tr National Mun Etf Etf (MUB)
Eli Lilly Common Stock (LLY)
Exxon Mobil Corp Common Stock (XOM)
Vanguard Bd Index Fds Intermed Term Etf (BIV)

View all positions for GAMMA Investing

Top funds holding Xtl Biopharmaceuticals

Noked Israel
SmartHarvest Portfolios
Rhumbline Advisers
GAMMA Investing
Morgan Stanley

View all funds holding Xtl Biopharmaceuticals